Cornerstone Investment Partners’s AngioDynamics ANGO Stock Holding History

Cornerstone Investment Partners’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$274K	Buy	+21,084	New	+$240K	0.01%	206
2025 Q3	–	Sell	-18,054	Closed	-$179K	–	212
2025 Q2	$179K	Buy	18,054 +8	+0%	+$78	0.01%	173
2025 Q1	$169K	Buy	+18,046	New	+$190K	0.01%	147
2022 Q1	–	Sell	-8,300	Closed	-$229K	–	233
2021 Q4	$229K	Buy	+8,300	New	+$229K	0.01%	202
2020 Q2	–	Sell	-12,960	Closed	-$135K	–	170
2020 Q1	$135K	Buy	+12,960	New	+$163K	0.01%	132

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.7M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

WCM

Weber Capital Management San Francisco, California $118M AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cornerstone Investment Partners's ANGO Position: Q2 2026 in Review

Cornerstone Investment Partners opened a new position in AngioDynamics (ANGO) in Q2 2026: 21,084 shares worth $274K. The stake represents 0.01% of the portfolio and ranks #206 among its holdings. This is a return to the name: Cornerstone Investment Partners previously reported a position in ANGO as recently as Q2 2025.

Cornerstone Investment Partners first reported a position in ANGO in Q1 2020 and has held it in 5 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

Cornerstone Investment Partners held 21,084 shares of AngioDynamics worth $274K as of Q2 2026.
AngioDynamics was a new Cornerstone Investment Partners position in Q2 2026.
AngioDynamics made up 0.01% of Cornerstone Investment Partners's portfolio in Q2 2026, its #206 holding.
Cornerstone Investment Partners first reported a position in AngioDynamics in Q1 2020 and has held it in 5 quarters since.
161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Cornerstone Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.